Additionally in GC and in hepatocellular carcinoma, Gal-3 activates GSK-3β, β-catenin, and the Insulin-like growth factor-binding protein 3; resulting in angiogenesis and EMT (80). The gene discussed is GSK3B; the disease is hepatocellular carcinoma.